DK1137430T3 - Terapeutikum til undertrykkelse af snorkelyde - Google Patents

Terapeutikum til undertrykkelse af snorkelyde

Info

Publication number
DK1137430T3
DK1137430T3 DK99964547T DK99964547T DK1137430T3 DK 1137430 T3 DK1137430 T3 DK 1137430T3 DK 99964547 T DK99964547 T DK 99964547T DK 99964547 T DK99964547 T DK 99964547T DK 1137430 T3 DK1137430 T3 DK 1137430T3
Authority
DK
Denmark
Prior art keywords
bont
clostridium toxin
carrier
added
tent
Prior art date
Application number
DK99964547T
Other languages
Danish (da)
English (en)
Inventor
Hans Bigalke
Juergen Frevert
Original Assignee
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh filed Critical Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh
Application granted granted Critical
Publication of DK1137430T3 publication Critical patent/DK1137430T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99964547T 1998-12-10 1999-12-10 Terapeutikum til undertrykkelse af snorkelyde DK1137430T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19856897A DE19856897A1 (de) 1998-12-10 1998-12-10 Therapeutikum zur Unterdrückung von Schnarchgeräuschen
PCT/EP1999/009791 WO2000033863A2 (de) 1998-12-10 1999-12-10 Therapeutikum zur unterdrückung von schnarchgeräuschen

Publications (1)

Publication Number Publication Date
DK1137430T3 true DK1137430T3 (da) 2003-06-16

Family

ID=7890562

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99964547T DK1137430T3 (da) 1998-12-10 1999-12-10 Terapeutikum til undertrykkelse af snorkelyde

Country Status (21)

Country Link
US (1) US6573241B1 (no)
EP (1) EP1137430B1 (no)
JP (1) JP4700811B2 (no)
KR (1) KR100859556B1 (no)
CN (1) CN1186095C (no)
AT (1) ATE234108T1 (no)
AU (1) AU764744B2 (no)
BR (1) BR9915800A (no)
CA (1) CA2353469A1 (no)
CZ (1) CZ295769B6 (no)
DE (2) DE19856897A1 (no)
DK (1) DK1137430T3 (no)
ES (1) ES2192880T3 (no)
HK (1) HK1040636B (no)
HU (1) HUP0104702A3 (no)
IL (2) IL143528A0 (no)
NO (1) NO328762B1 (no)
PL (1) PL202908B1 (no)
PT (1) PT1137430E (no)
RU (1) RU2243783C2 (no)
WO (1) WO2000033863A2 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19925739A1 (de) * 1999-06-07 2000-12-21 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Therapeutikum mit einem Botulinum-Neurotoxin
US20080038274A1 (en) 1999-09-23 2008-02-14 Foster Keith A Inhibition of secretion from non-neuronal cells
DE10035156A1 (de) * 2000-07-19 2002-02-07 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Proteinkomplex als Vehikel für oral verfügbare Protein-Arzneimittel
US20100104631A1 (en) * 2001-08-13 2010-04-29 Lipella Pharmaceuticals Inc. Method of treatment for bladder dysfunction
US7763663B2 (en) * 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
US7691394B2 (en) * 2002-05-28 2010-04-06 Botulinum Toxin Research Associates, Inc. High-potency botulinum toxin formulations
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
US7183066B2 (en) * 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
CA2518650A1 (en) * 2004-09-10 2006-03-10 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
WO2006138127A2 (en) * 2005-06-14 2006-12-28 Botulinum Toxin Research Associates, Inc. Botulinum toxin and the treatment of primary disorders of mood and affect
US8926991B2 (en) 2005-06-14 2015-01-06 Botulinum Toxin Research Associates, Inc. Botulinum toxin and the treatment of primary disorders of mood and affect
US20150258183A1 (en) 2006-06-07 2015-09-17 Botulinum Toxin Research Associates, Inc. Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
CA2618655C (en) 2005-07-18 2015-12-22 University Of Massachusetts Lowell Compositions and methods for making and using nanoemulsions
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
DK3144013T3 (en) 2005-12-01 2019-03-04 Univ Massachusetts Lowell Botulinum nanoemulsions
US10792344B2 (en) 2006-06-29 2020-10-06 Merz Pharma Gmbh & Co. Kgaa High frequency application of botulinum toxin therapy
AR061669A1 (es) 2006-06-29 2008-09-10 Merz Pharma Gmbh & Co Kgaa Aplicacion de alta frecuencia de terapia con toxina botulinica
BRPI0719756A2 (pt) * 2006-12-01 2014-01-21 Anterios Inc Nanopartículas de entidades anfifílicas
BRPI0719732A2 (pt) 2006-12-01 2017-05-16 Anterios Inc nanopartículas de peptídeo e usos para as mesmas
KR20100050443A (ko) 2007-05-31 2010-05-13 안테리오스, 인코퍼레이티드 핵산 나노입자 및 이의 용도
CN105147608B (zh) * 2008-06-26 2019-12-10 安特里奥公司 真皮递送
WO2010096134A1 (en) 2008-12-04 2010-08-26 Botulinum Toxin Research Associates, Inc. Extended length botulinum toxin formulation for human or mammalian use
US20100166739A1 (en) * 2008-12-30 2010-07-01 Lipella Paharmaceuticals Inc. Methods and Compositions for Diagnosing Urological Disorders
JP2013510193A (ja) * 2009-11-09 2013-03-21 サンダース，イラ 神経毒を用いる睡眠呼吸障害の処置
EP2677029B1 (en) 2011-05-19 2017-05-10 Ipsen Bioinnovation Limited Methods for the manufacture of proteolytically processed polypeptides
US9393291B2 (en) 2012-04-12 2016-07-19 Botulinum Toxin Research Associates, Inc. Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds
JP6156954B2 (ja) 2012-11-21 2017-07-05 イプセン バイオイノベーション リミテッド タンパク分解性にプロセシングされたポリペプチドの製造方法
GB201407525D0 (en) 2014-04-29 2014-06-11 Syntaxin Ltd Manufacture of recombinant clostridium botulinum neurotoxins
US11484580B2 (en) 2014-07-18 2022-11-01 Revance Therapeutics, Inc. Topical ocular preparation of botulinum toxin for use in ocular surface disease
US9901627B2 (en) 2014-07-18 2018-02-27 Revance Therapeutics, Inc. Topical ocular preparation of botulinum toxin for use in ocular surface disease
US11311496B2 (en) 2016-11-21 2022-04-26 Eirion Therapeutics, Inc. Transdermal delivery of large agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551473A (en) * 1984-04-26 1985-11-05 Schossow George W Method of inhibiting snoring and obstructive sleep apnea
CA2138020C (en) * 1992-06-23 1999-02-16 Eric A. Johnson Pharmaceutical composition containing botulinum b complex
AU683275B2 (en) * 1993-06-10 1997-11-06 Allergan, Inc. Multiple botulinum toxins for treating neuromuscular disorders and conditions
EP1598077B1 (en) * 1993-12-28 2009-11-04 Allergan, Inc. Use of the neurotoxic component of botulinum toxins for the treatment of a spastic muscle
US5512547A (en) * 1994-10-13 1996-04-30 Wisconsin Alumni Research Foundation Pharmaceutical composition of botulinum neurotoxin and method of preparation
US5756468A (en) * 1994-10-13 1998-05-26 Wisconsin Alumni Research Foundation Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation
SE9504537D0 (sv) * 1995-12-19 1995-12-19 Jan Hedner Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
US5721215A (en) * 1996-03-20 1998-02-24 Allergan Injectable therapy for control of muscle spasms and pain related to muscle spasms
US9354569B2 (en) 2013-06-13 2016-05-31 Lexmark International, Inc. Heat transfer system for a fuser assembly

Also Published As

Publication number Publication date
HUP0104702A2 (hu) 2002-04-29
IL143528A0 (en) 2002-04-21
PL202908B1 (pl) 2009-08-31
BR9915800A (pt) 2001-09-25
PL349334A1 (en) 2002-07-15
JP2002531516A (ja) 2002-09-24
CZ295769B6 (cs) 2005-11-16
HUP0104702A3 (en) 2003-09-29
US6573241B1 (en) 2003-06-03
JP4700811B2 (ja) 2011-06-15
ATE234108T1 (de) 2003-03-15
AU3037400A (en) 2000-06-26
HK1040636B (zh) 2003-05-30
WO2000033863A2 (de) 2000-06-15
CN1329501A (zh) 2002-01-02
DE59904569D1 (de) 2003-04-17
ES2192880T3 (es) 2003-10-16
CZ20012058A3 (cs) 2001-09-12
KR100859556B1 (ko) 2008-09-22
AU764744B2 (en) 2003-08-28
WO2000033863A3 (de) 2000-11-02
RU2243783C2 (ru) 2005-01-10
NO20012716D0 (no) 2001-06-01
EP1137430B1 (de) 2003-03-12
PT1137430E (pt) 2003-07-31
EP1137430A2 (de) 2001-10-04
CN1186095C (zh) 2005-01-26
HK1040636A1 (en) 2002-06-21
NO20012716L (no) 2001-06-01
DE19856897A1 (de) 2000-06-15
KR20010089527A (ko) 2001-10-06
IL143528A (en) 2008-04-13
NO328762B1 (no) 2010-05-10
CA2353469A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
DK1137430T3 (da) Terapeutikum til undertrykkelse af snorkelyde
TR200002179T2 (tr) Kristalin teriparatid.
AU1593001A (en) Recombinant gelatin in vaccines
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
ATE552891T1 (de) Kombination von sauren-proteaseenzymen und sauren pufferlösungen sowie deren verwendung
BG100974A (en) Vaccines against papillomavirus
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
WO2004110472A3 (en) Fusion proteins
ES2227527T3 (es) Un factor de crecimiento de queratinocitos (kgf) truncado que tiene actividad biologica aumentada.
IS4265A (is) Afleiður af mycophenolicsýrum, sem hafa efnahópa tengda-N-atómi í stöðu 6
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
DE69826684D1 (de) Kovalent gebundenes n,o-carboxymethylchitosan und seine verwendungen
WO2002038775A3 (en) METHODS FOR PRODUCING AND PURIFYING RECOMBINANT α-L-IDURONIDASE
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
TR199900770T2 (xx) Nazal poliplerin tedavisinde bir H+, K+-ATPase'�n kullan�lmas�.
ATE272648T1 (de) Glycokonjugate von 20(s)-camptothecin
MXPA03007992A (es) Composicion farmaceutica de fragmentos f(ab)2 de anticuerpos y un proceso para su preparacion
ATE338819T1 (de) Antigenes protein aus malassezia
AU7030700A (en) Preparation of highly pure toxin fragments
DE69635806D1 (de) Diphosphonat derivate von therapeutisch wirksamen stoffen
WO2000042987A3 (en) Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections
AU1875395A (en) 4-amino derivatives of 5-substituted mycophenolic acid
ATE254469T1 (de) Verfahren zur verminderung der renalen aufnahme von antikörperfragmenten
DK0934342T3 (da) Præparat indeholdende chitosan
PT1105503E (pt) Guanililciclase humana soluvel alfal/betal (hsgc alfal/betal) isolada e purificada